• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较急诊手术与纤溶治疗用于治疗左侧人工心脏瓣膜血栓形成:一项观察性研究的系统回顾和荟萃分析。

Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies.

机构信息

Department of Cardiology, Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

出版信息

Eur Heart J. 2013 Jun;34(21):1557-66. doi: 10.1093/eurheartj/ehs486. Epub 2013 Jan 17.

DOI:10.1093/eurheartj/ehs486
PMID:23329151
Abstract

AIMS

Left-sided prosthetic valve thrombosis (PVT) occurs frequently in developing countries and causes major morbidity and mortality. Fibrinolytic therapy (FT) is most commonly used as treatment, but increases the risk of stroke and bleeding. Urgent surgery may be more efficacious and cause fewer complications. Our aim was to compare the efficacy and safety of urgent surgery and FT for the treatment of left-sided PVT.

METHODS AND RESULTS

We searched EMBASE and MEDLINE for articles which included at least five patients each treated with surgery and FT. The primary outcome was complete restoration of valve function. Other outcomes were in-hospital death, thrombo-embolism (stroke, transient ischaemic attack, or non-CNS systemic embolism), major bleeding, and recurrence of PVT on follow-up. We calculated odds ratios (ORs) for each outcome and pooled them using a random effects model. We included seven eligible studies with 690 episodes of PVT, 446 treated with surgery, and 244 with FT. There was no significant difference in the occurrence of the primary outcome (86.5 vs. 69.7%, OR 2.53, 95% CI 0.94-6.78, P = 0.066, I(2) = 74%) or death (13.5 vs. 9%, OR 1.95, 95% CI 0.63-5.98, P = 0.244, I(2) = 59%) between the two treatments. However, compared with FT, urgent surgery was associated with significant reductions in thrombo-embolism (1.6 vs. 16%, OR 0.10, 95% CI 0.04-0.24, P < 0.001, I(2) = 0%), major bleeding (1.4 vs. 5%; OR 0.27, 95% CI 0.08-0.98, P = 0.046, I(2) = 0%), and recurrent PVT (7.1 vs. 25.4%; OR 0.25, 95% CI 0.08-0.74, P = 0.013, I(2) = 59%).

CONCLUSION

Urgent surgery was not superior to FT at restoring valve function, but substantially reduced the occurrence of thrombo-embolic events, major bleeding, and recurrent PVT. In experienced centres, urgent surgery should probably be preferred over FT for treating left-sided PVT, pending the results of randomized controlled trials.

摘要

目的

左心人工瓣膜血栓形成(PVT)在发展中国家较为常见,可导致严重的发病率和死亡率。纤溶治疗(FT)是最常用的治疗方法,但会增加中风和出血的风险。紧急手术可能更有效且引起的并发症更少。我们的目的是比较紧急手术和 FT 治疗左心 PVT 的疗效和安全性。

方法和结果

我们在 EMBASE 和 MEDLINE 上搜索了至少各有 5 例患者接受手术和 FT 治疗的文章。主要结局是瓣膜功能完全恢复。其他结局包括住院期间死亡、血栓栓塞(中风、短暂性脑缺血发作或非中枢神经系统系统性栓塞)、大出血以及随访期间 PVT 复发。我们计算了每个结局的优势比(OR),并使用随机效应模型对其进行了汇总。我们纳入了 7 项符合条件的研究,共 690 例 PVT 患者,其中 446 例接受手术治疗,244 例接受 FT 治疗。两种治疗方法在主要结局(86.5% vs. 69.7%,OR 2.53,95%CI 0.94-6.78,P = 0.066,I(2) = 74%)或死亡(13.5% vs. 9%,OR 1.95,95%CI 0.63-5.98,P = 0.244,I(2) = 59%)的发生率方面无显著差异。然而,与 FT 相比,紧急手术与血栓栓塞(1.6% vs. 16%,OR 0.10,95%CI 0.04-0.24,P < 0.001,I(2) = 0%)、大出血(1.4% vs. 5%;OR 0.27,95%CI 0.08-0.98,P = 0.046,I(2) = 0%)和 PVT 复发(7.1% vs. 25.4%;OR 0.25,95%CI 0.08-0.74,P = 0.013,I(2) = 59%)的发生率显著降低。

结论

紧急手术在恢复瓣膜功能方面并不优于 FT,但可显著降低血栓栓塞事件、大出血和 PVT 复发的发生率。在经验丰富的中心,对于治疗左心 PVT,紧急手术可能优于 FT,有待随机对照试验的结果。

相似文献

1
Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies.比较急诊手术与纤溶治疗用于治疗左侧人工心脏瓣膜血栓形成:一项观察性研究的系统回顾和荟萃分析。
Eur Heart J. 2013 Jun;34(21):1557-66. doi: 10.1093/eurheartj/ehs486. Epub 2013 Jan 17.
2
Comparison between surgery and fibrinolytic therapy in prosthetic valve thrombosis: A systematic review and meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗冠状动脉多支病变的对比:一项系统评价和荟萃分析
J Card Surg. 2022 Sep;37(9):2776-2785. doi: 10.1111/jocs.16681. Epub 2022 Jun 14.
3
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
4
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.用于预防外周动脉搭桥术后血栓形成的抗血小板药物。
Cochrane Database Syst Rev. 2015 Feb 19;2015(2):CD000535. doi: 10.1002/14651858.CD000535.pub3.
7
Negative pressure wound therapy for surgical wounds healing by primary closure.负压伤口疗法在一期缝合手术伤口愈合中的应用。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD009261. doi: 10.1002/14651858.CD009261.pub7.
8
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.在择期初次髋关节或膝关节置换术或髋部骨折修复中,直接凝血因子Xa抑制剂与低分子量肝素或维生素K拮抗剂用于预防静脉血栓栓塞的比较
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD011762. doi: 10.1002/14651858.CD011762.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial.
Eur Heart J. 2025 Sep 8;46(34):3373-3381. doi: 10.1093/eurheartj/ehaf391.

引用本文的文献

1
Thrombolysis in dysfunctional valve and stroke.功能失调瓣膜与中风的溶栓治疗。
World J Crit Care Med. 2025 Jun 9;14(2):96624. doi: 10.5492/wjccm.v14.i2.96624.
2
Mechanical prosthetic valve thrombosis after ChAdOx1-nCoV-19 vaccination: A case report.ChAdOx1-nCoV-19疫苗接种后机械人工瓣膜血栓形成:一例报告。
IHJ Cardiovasc Case Rep. 2022 Oct-Dec;6(4):169-171. doi: 10.1016/j.ihjccr.2022.09.008. Epub 2022 Oct 7.
3
Thrombosed Mechanical Aortic Valve Treated with Low-Dose Ultraslow Alteplase Infusion.低剂量超慢速阿替普酶输注治疗血栓形成的机械主动脉瓣
Medicines (Basel). 2025 Feb 2;12(1):3. doi: 10.3390/medicines12010003.
4
Acute Decompensated Valvular Disease in the Intensive Care Unit.重症监护病房中的急性失代偿性瓣膜病
JACC Adv. 2024 Dec 26;3(12):101402. doi: 10.1016/j.jacadv.2024.101402. eCollection 2024 Dec.
5
Surgery Versus Thrombolytic Therapy for the Management of Left-Sided Prosthetic Valve Thrombosis Without Hemodynamic Compromise: A Systematic Review and Meta-Analysis.手术与溶栓治疗用于无血流动力学障碍的左心人工瓣膜血栓形成的比较:系统评价和荟萃分析。
J Am Heart Assoc. 2024 Oct;13(19):e035143. doi: 10.1161/JAHA.124.035143. Epub 2024 Sep 18.
6
Surgery compared to fibrinolytic therapy for symptomatic left-sided prosthetic heart valve thrombosis (SAFE-PVT): Rationale and design of a randomized controlled trial.手术与纤溶治疗症状性左侧人工心脏瓣膜血栓形成(SAFE-PVT)的比较:一项随机对照试验的原理和设计。
Indian Heart J. 2024 May-Jun;76(3):192-196. doi: 10.1016/j.ihj.2024.06.013. Epub 2024 Jun 14.
7
Thrombolytic therapy after cardiac arrest in patients with mechanical aortic valve thrombosis.机械性主动脉瓣血栓形成患者心脏骤停后的溶栓治疗。
J Cardiol Cases. 2023 Dec 7;29(3):112-115. doi: 10.1016/j.jccase.2023.11.007. eCollection 2024 Mar.
8
Tertiary prevention and treatment of rheumatic heart disease: a National Heart, Lung, and Blood Institute working group summary.风湿性心脏病的三级预防与治疗:美国国立心肺血液研究所工作组总结。
BMJ Glob Health. 2023 Oct;8(Suppl 9). doi: 10.1136/bmjgh-2023-012355.
9
[Valve thrombosis and thrombolytic therapy in modern era: a case report].[现代瓣膜血栓形成与溶栓治疗:一例报告]
Arch Peru Cardiol Cir Cardiovasc. 2021 Sep 30;2(3):196-199. doi: 10.47487/apcyccv.v2i3.149. eCollection 2021 Jul-Sep.
10
The role of multidetector CT scan in the management of prosthetic aortic valve thrombosis: A case report.多排螺旋CT扫描在人工主动脉瓣血栓管理中的作用:一例病例报告。
Clin Case Rep. 2023 Aug 29;11(9):e7824. doi: 10.1002/ccr3.7824. eCollection 2023 Sep.